LBPH | Longboard Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	59.98 - 59.98
52 Week Range	3.82 - 60.03
Beta	1.75
Implied Volatility	38.65%
IV Rank	8.24%
Day's Volume	655,798
Average Volume	1,730,860
Shares Outstanding	39,045,702
Market Cap	2,341,961,206
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-03-12

Valuation
Profitability
Growth
Health
P/E Ratio	-26.66
Forward P/E Ratio	N/A
EPS	-2.25
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	50
Country	USA
Website	LBPH

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

LBPH's peers: APTO, CLRB, CMMB, MOLN, MNOV, ANEB, CSBR, CYT, HOWL, EWTX, DBTX, CELC, CCCC, ASMB, NXTC, NUVB, GRPH, TIL, SNSE, MACK, GLUE, DSGN, IKNA, STOK, SVRA

*Chart delayed

Analyzing fundamentals for LBPH we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see LBPH Fundamentals page.

Watching at LBPH technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on LBPH Technicals page.